30
Participants
Start Date
November 28, 2018
Primary Completion Date
June 30, 2021
Study Completion Date
June 30, 2021
Trimetazidine
Subjects with receive up to 60 mg daily
Medical University of Graz, Graz
Medical University of Innsbruck, Innsbruck
Medical University of Vienna, Vienna
University of Antwerp, Antwerp
Erasme Hospital, Brussels
Hospital Claude Huriez, Lille
Hospital Pitie-Salpetriere, Paris
Rennes University Hospital, Rennes
Hôpital Paul Brousse, Villejuif
University of Essen, Essen
JW Goethe Clinic, Frankfurt
Universitätsklinikum Halle Klinik und Poliklinik für Innere Medizin I, Halle
University of Hannover, Hanover
University of Heidelberg, Heidelberg
University of Leipzig, Leipzig
University of Münster, Münster
Hospital Clinic, Barcelona
Hospital Valle de Hebron, Barcelona
Hospital Reina Sofia, Córdoba
Hospital Gregorio Marañón, Madrid
Hospital Puerta de Hierro, Madrid
Hospital Ramon y Cajal, Madrid
Hospital Marques de Valdecilla Santander, Santander
Hospital Virgen del Rocio, Seville
Lead Sponsor
Martin Pharmaceuticals
INDUSTRY